You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. A device for rapid, painless, bedside muscle evaluation of children with neuromus

    SBC: MYOLEX, INC.            Topic: 105

    DESCRIPTION provided by applicant The neuromuscular assessment of children is uniquely challenging Unlike examination of the heart or lung the complete bedside assessment of the neuromuscular system requires the active participation of the child and results must be evaluated in the context of normal child development and degree of cooperation Moreover neuromuscular disease severity is highl ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  2. Bone Conduction Testing for Newborn Hearing Screening

    SBC: INTELLIGENT HEARING SYSTEMS CORP            Topic: NIDCD

    DESCRIPTION provided by applicant This study aims to develop an improved neonatal hearing screening device that will incorporate novel testing procedures combining simultaneous air and bone conduction testing so that mild hearing losses andlt dB nHL are better and consistently detected The proposed device will address the current need for a more sensitive hearing screening tool by stimul ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  3. Cheap and fast ambient air monitoring of pesticides

    SBC: ISENSE, LLC            Topic: NIEHS

    DESCRIPTION provided by applicant Acute pesticide poisoning remains a vast health problem in the developed and developing world Domestically a study estimates that of every US agricultural workers suffer from acute pesticide poisoning On top of that long time effects have also been observed with an increased risk for lymphomas and prostate brain leukemia cervix and stomac ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  4. Development of a WNT Inhibitor for Advanced Stage Lung Cancer

    SBC: Stemsynergy Therapeutic            Topic: 102

    DESCRIPTION provided by applicant Non small cell lung cancer NSCLC is the most common lung cancer Half of NSCLC shows WNT activation marking poor survival StemSynergy Therapeutics Inc SSTI has identified a family of WNT inhibitors based on a novel chemical scaffold with our lead molecule SST demonstrating efficacy against WNT driven colorectal cancer In Phase I SBIR studies many ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  5. Development of molecular assays for non-invasive bladder cancer detection

    SBC: NONAGEN BIOSCIENCE CORPORATION            Topic: 102

    DESCRIPTION provided by applicant Bladder cancer BCa is among the five most common malignancies worldwide In the US alone new BCa cases for are estimated at with estimated deaths at At presentation the majority of bladder tumors are non muscle invasive and can be treated by transurethral resection of the tumor however more than of patients with BCa will have a re ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  6. Engineering of Human Corneal Endothelial Grafts

    SBC: BIOTISSUE HOLDINGS INC.            Topic: W

    DESCRIPTION provided by applicant The corneal endothelium plays a pivotal role in maintaining corneal transparency Unlike in other species the human corneal endothelium is notorious for its limited proliferative capacity in vivo after diseases injury aging and surgery Persistent corneal endothelial dysfunction leads to sight threatening bullous keratopathy Presently the only solution to ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  7. HHSN261201400018C;EPOTHILONE D FORMULATED IN POLYMER MICELLE NANOPARTICLES; POP: 09/17/2014 TO 05/16/2016

    SBC: INTEZYNE TECHNOLOGIES, INC.            Topic: NCI

    This project aims to optimize the lead formulation of epothilone D encapsulated in a stable nanoparticle for the treatment of solid malignancies, and assist in providing for the GMP manufacturing and GLP toxicology studies required for IND submission and translation into human clinical trials. The optimized formulation should demonstrate improvements in plasma pharmacokinetics in a cannulated rat ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  8. HHSN261201400045CTITLE: SBIR TOPIC 306?ALGORITHMS FOR ANALYSIS OF IN VIVO IMAGES?;TITLE: SBIR TOPIC 306 ENTITLED:?SCALABLE AUTOMATED BRAIN TUMOR SEGMENTATION?;24 MONTHS FUNDING-PHASE II;09/16/2014

    SBC: INFOTECH SOFT, INC.            Topic: NCI

    Not Available

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  9. IL-15 Superagonist Complex as an Immunotherapeutic for Multiple Myeloma

    SBC: Altor BioScience, LLC            Topic: 102

    DESCRIPTION provided by applicant Multiple myeloma MM is the second most commonly diagnosed hematologic malignancy with an estimated newly diagnosed cases and deaths due to MM in the United States in MM typically a disease of the elderly is a malignancy of clonal plasma cells in the bone marrow BM characterized by the presence of paraproteinemia destructive bone dise ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
  10. Novel IL-15 Superagonist Therapy for Bladder Cancer

    SBC: Altor BioScience, LLC            Topic: 102

    DESCRIPTION provided by applicant Bladder cancer is the fifth most common cancer in the United States Over of patients initially present with non muscle invasive bladder cancer NMIBC confined to the mucosa of the bladder These patients are treated by tumor resection followed by intravesical chemotherapy or Bacillus Calmette Gu rin BCG therapy Despite treatment of NMIBC pat ...

    SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government